Genetic Technologies Limited announced the appointment of Michael Tonroe to the role of Chief Financial Officer, commencing on 28 June 2021. Michael has over 25 years experience in overseeing the finance function at both management and board level positions for private and listed companies in Australia, UK, US and Canada. He also has extensive experience in the biotech space across both the financial and company secretary roles having most recently managed both functions for Opthea Limited. Prior to his most recent role as CFO and company secretary at Opthea Michael was CFO and company secretary at the Australian Synchroton in Melbourne.